Blog

BBKWorldwide

Recent Posts

Country- and Site-Level Considerations for Informed Site Selection

By BBKWorldwide on Fri, Nov 6, 2015

Choosing the right countries and sites for a particular study remains one of the industry’s biggest challenges – but it doesn’t have to be. When the time comes to select sites for your clinical research study, there are many considerations that can guide your decisions to ensure the best possible outcome.

Topics: Site Selection

BIO Notifier: For the Advancement of Global Clinical Research

By BBKWorldwide on Mon, Oct 26, 2015

A recent survey conducted on behalf of the National Institute for Health Research Clinical Research Network shows that 89% of people would be willing to take part in a clinical trial if they were diagnosed with a medical condition or disease. This figure has very positive implications for the enterprise of global clinical research, as patient enrollment is one of the defining aspects of its success. So why is it that half of all investigative sites under-enroll for patients, and 11% of sites fail to enroll a single patient for a clinical trial?

Part II: Top Trends Paving the Way for Clinical Trial Success

By BBKWorldwide on Thu, Sep 3, 2015

In last week’s post I focused on how socio-techno advancements, a balanced patient outreach plan, and optimal outreach strategies work to enhance patient recruitment and engagement. While those three trends are painting a picture for how to optimize the clinical trial practices of the future, there are two more top trends that will help to round out any campaign.

Topics: Patient Engagement, clinical trials

Top Trends Paving the Way for Clinical Trial Success

By BBKWorldwide on Thu, Aug 27, 2015

We recently posted about the consumerization of health care that is truly driving change. Today I’d like to look at a few trends to keep an eye on that will prepare us for clinical trial success in the coming years.

Topics: clinical trials

The Keys to Future Patient Recruitment Success

By BBKWorldwide on Fri, Aug 21, 2015

At the 2015 DIA Annual Meeting this past June there was a lot of talk about how technology is impacting the way we interact with patients, sites, and other key players in the clinical study landscape. When I sat down with three other industry experts to discuss bringing clinical trial practices into the 21st century, I shifted the talk to focus on the forces that drive the way we communicate with patients and with each other within our industry. Furthermore, how can we look at today’s trends to better predict the future of patient recruitment and engagement?

Topics: Patient Recruitment

Adaptive Recruitment Strategies for Rare Disease: Part III

By BBKWorldwide on Thu, Aug 20, 2015

Part I of our blog series on adaptive patient recruitment focused on the importance of early support. Part II looked at how to best analyze investigator resources to optimize patient recruitment efforts, including cultivating integrated relationships. Today we wrap up our rare disease series on recruitment with two final tactics that can yield strong results.

Topics: Rare Disease

BBK and The Diabetes Collective Talk the Future of Patient Centricity

By BBKWorldwide on Thu, Aug 13, 2015

Topics: Patient Centricity

Raising the Patient Voice, Insights from the Michael J. Fox Foundation and BBK

By BBKWorldwide on Tue, Aug 11, 2015

At the 2015 DIA Annual Meeting in June, we sat down PharmaVOICE Editor Taren Grom and Claire Meunier, Vice President of Research Engagement at the Michael J. Fox Foundation for a conversation about patient centricity and the role technology is playing and will continue to play as we move forward.

Topics: Patient Centricity, Technology

Key Takeaways from 51st Annual DIA Meeting

By BBKWorldwide on Tue, Jun 30, 2015

With another successful DIA Annual Meeting behind us, as well as some time to reflect, we wanted to thank our industry partners and colleagues for making this year’s meeting one of the best yet. We also want to highlight some of the thought-provoking work and innovations that raised the already high bar. Here goes.

Topics: Patient Centricity

Adaptive Patient Recruitment for Rare Disease: Early Support is Key

By BBKWorldwide on Wed, Jun 3, 2015

There is a huge unmet need in the rare disease community to invest in developing treatments. According to the US advocacy group Global Genes, there are more than 7,000 distinct rare diseases affecting 350,000,000 people worldwide and only 400 approved therapies. How can we adapt traditional recruitment strategies to target the right patients? The goal is to create tailored adaptive strategies aimed at extending reach and building relationships. There are many ways in which this can be done. In this first post of a series focused on adaptive recruitment for rare disease, I will explore the introduction of an early support program.

Topics: Patient Recruitment, Rare Disease

 

Subscribe To Our Blog